L. S. Sorokina

L. S. Sorokina

Auto-generated profile, based on publicly available information

L. S. Sorokina

Petrovsky National Research Centre of Surgery

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in S.S. Korsakov Journal of Neurology and Psychiatry
Verified
Journal Article
Closed access
AEA.A. Eremenko
A.A. Eremenko
LSL.S. Sorokina
L.S. Sorokina
DRD.V. Ryabova
D.V. Ryabova
AUA.V. Urbanov
A.V. Urbanov
ЦЕЛЬ ИССЛЕДОВАНИЯ Оценка эффективности мультимодальной схемы послеоперационного обезболивания на основе фиксированной комбинации орфенадрина и диклофенака (препарат Неодолпассе) на фоне контролируемой пациентом аналгезии (КПА) морфином в раннем послеоперационном периоде у кардиохирургических больных. МАТЕРИАЛ И МЕТОДЫ В ходе проспективного рандомизированного сравнительного исследования оценивали две схемы послеоперационного обезболивания. У 20 пациентов 1-й группы сразу после экстубации трахеи назначали препарат Неодолпассе. Повторную инфузию выполняли при интенсивности боли по визуально-аналоговой шкале (ВАШ) >50 мм не ранее, чем через 12 ч после первой. КПА морфином начинали через 2 ч после экстубации. Во 2-ю группу вошли 20 пациентов, обезболивание которым проводили методом КПА морфином. Интенсивность болевого синдрома во время двигательной активности пациента (кашель, глубокий вдох) и в покое оценивали по ВАШ, в качестве дополнительного объективного критерия эффективности аналгезии использовали метод побудительной спирометрии. РЕЗУЛЬТАТЫ Снижение выраженности болевого синдрома по ВАШ в среднем с 41 до 19 мм (p=0,036) достигалось уже к 1-му часу от начала инфузии Неодолпассе, и у 80% больных этот эффект сохранялся в течение 24 ч. Двум пациентам через 12 ч потребовалось введение второй дозы. Поскольку инфузию морфина начинали через 2 ч после экстубации трахеи, у больных 2-й группы значимое снижение интенсивности боли отмечалось только к 4 ч, а достоверные различия в выраженности боли в обеих группах сохранялись практически на всех стадиях исследования. Анальгетический эффект Неодолпассе сопровождался положительным влиянием на функцию внешнего дыхания с увеличением максимальной инспираторной емкости легких в 1,5 раза по сравнению с исходным. Во 2-й группе нежелательные явления также были связаны с применением морфина и зависели от его дозы. Осложнений, связанных с Неодолпассе, не было отмечено. Суточный расход морфина на 1 больного во 2-й группе составил в среднем 22,6 мг, а в 1-й группе — 9,35 мг (p<0,001). ЗАКЛЮЧЕНИЕ Продемонстрированы высокий анальгетический и значимый опиоидсберегающий эффекты, а также безопасность применения Неодолпассе в раннем послеоперационном периоде после кардиохирургических вмешательств.

1 January 2022 in Clinical and Experimental Surgery. Petrovsky journal
Verified
Journal Article
Closed access
MBMAXIM BABAEV
MAXIM BABAEV
AEA.A. Eremenko
A.A. Eremenko
TZT.P. Zyulyaeva
T.P. Zyulyaeva
MGMarina Grekova
Marina Grekova
OGOxana Olegovna Grin
Oxana Olegovna Grin
SDS.S. Dmitrieva
S.S. Dmitrieva
Коррекция эндотоксемии и профилактика шока с помощью многократной сорбции липополисахарида: описание клинического случая и анализ данных литературы

21 April 2026 in Messenger of ANESTHESIOLOGY AND RESUSCITATION
Verified
Journal Article
Open access
PDF file
LSL. S. Sorokina
L. S. Sorokina
SYS. S. Yudina
S. S. Yudina
DFD. V. Fomina
D. V. Fomina
MSM. A. Semenkov
M. A. Semenkov
FTF. Ya. Tukhasheva
F. Ya. Tukhasheva
AEA. A. Eremenko
A. A. Eremenko
Introduction. Perioperative disturbances of energy metabolism in cardiac surgery patients significantly affect postoperative course and outcomes. Under conditions of surgical stress and cardiopulmonary bypass (CPB), conventional approaches to metabolic assessment have limited diagnostic value. The objective was to evaluate perioperative changes in cardiorespiratory function and energy metabolism in cardiac surgery patients with uncomplicated operations performed under general anesthesia using CPB. Materials and methods . Thirty patients were included in the study. Metabolic and hemodynamic parameters were assessed at four stages: after anesthesia induction, during sternotomy, before CPB initiation, and in the early post-perfusion period. Indirect calorimetry (IC) was used to measure oxygen consumption (VO2), carbon dioxide production (VCO 2 ), resting energy expenditure (REE), and respiratory quotient (RQ). Central hemodynamics were evaluated using transesophageal echocardiography. Blood gas parameters, lactate, and glucose levels were also analyzed. Results . The lowest VO 2 index values were recorded after anesthesia induction (106.55 ± 30.69 ml∙min –1 ⋅m –2 ), reflecting a state of pharmacologically induced metabolic suppression. From the sternotomy stage onward, a persistently increased level of energy expenditure was observed until the end of surgery. In the early post-perfusion period, VO 2 I index increased to 166.59 ± 44.69 ml ⋅ min –1 ⋅ m –2 , exceeding values calculated by the reverse Fick method by 76%. Predictive equations (Harris–Benedict) underestimated actual energy requirements by an average of 29%. Reduced RQ values (0.54–0.59) indicated predominant lipid substrate utilization. After CPB discontinuation, blood lactate levels increased 2.5-fold and blood glucose levels by 36%. A significant correlation between VO 2 and cardiac output was observed (r = 0.63; p = 0.001). Conclusion . Perioperative changes in energy metabolism are stage-dependent and predominantly adaptive in nature. Indirect calorimetry enables objective assessment of metabolic and perfusion status at different stages of cardiac surgery.

22 October 2026 in Messenger of ANESTHESIOLOGY AND RESUSCITATION
Verified
Journal Article
Open access
PDF file
LSL. S. Sorokina
L. S. Sorokina
OVO. N. Vasileva
O. N. Vasileva
NNN. M. Nemchinova
N. M. Nemchinova
FTF. Ya. Tukhasheva
F. Ya. Tukhasheva
AEA. A. Eremenko
A. A. Eremenko
АЕА. А. Еременко
А. А. Еременко
Introduction . Moderate-to-severe postoperative pain may persist after coronary artery bypass grafting (CABG) despite baseline multimodal analgesia. The choice of an additional analgesic should take into account not only analgesic efficacy but also its safety profile. The objective was to compare the early effects of tafalgin and trimeperidine administered as adjuncts to baseline intravenous paracetamol analgesia in the early postoperative period after CABG. Materials and Methods . Sixty patients undergoing CABG were randomized using the sealed-envelope method into two groups (30 patients each). All patients received intravenous paracetamol (1 g four times daily), with the first dose administered 30 minutes before tracheal extubation. After extubation, patients experiencing their first pain episode with a visual analogue scale (VAS) score > 40 mm received a single dose of either intramuscular trimeperidine 20 mg or subcutaneous tafalgin 7 mg. Pain intensity (VAS), sedation level assessed using the Richmond Agitation–Sedation Scale (RASS), hemodynamic parameters, peripheral oxygen saturation (SpO₂), adverse events, and the need for rescue analgesia were evaluated before study drug administration and at 15, 30, 45, 60, and 120 minutes thereafter. Patients with persistent pain (VAS > 40 mm) at 60 minutes received intravenous nefopam 20 mg as rescue analgesia. Results . Baseline pain intensity did not differ between the groups: 58 [50–60] mm in the trimeperidine group and 60 [50–65] mm in the tafalgin group ( p = 0.49). At 15 minutes, pain intensity was lower in the trimeperidine group (38 [35–40] vs 45 [42–50] mm; p = 0.0006). No significant between-group differences in pain intensity were observed at 30, 45, 60, or 120 minutes. Heart rate was higher in the tafalgin group at 15 and 30 minutes ( p < 0.0001), whereas this difference was no longer significant by 45 minutes. Mild sedation (RASS −1) occurred more frequently in the trimeperidine group (57% vs 13%; p = 0.009). Nausea and vomiting were also more frequent after trimeperidine, although the differences did not reach statistical significance. The requirement for rescue analgesia with nefopam was comparable between the groups (17% vs 23%). Conclusion . A single 7 mg dose of tafalgin provided effective postoperative pain relief. Although trimeperidine produced faster pain relief during the first 15 minutes after administration, no significant differences in analgesic efficacy were observed thereafter. Tafalgin was associated with less sedation and a trend toward a lower incidence of postoperative nausea and vomiting, without increasing the need for rescue analgesia.

28 July 2023 in Annals of Critical Care
Verified
Journal Article
Open access
PDF file
АЕАлександр Анатольевич Еременко
Александр Анатольевич Еременко
DFD. V. Fomina
D. V. Fomina
RKR. D. Komnov
R. D. Komnov
LSL. S. Sorokina
L. S. Sorokina
AUA. V. Urbanov
A. V. Urbanov
INTRODUCTION: The frequency of respiratory failure in the postoperative period is 17–22 % [1–3]. The most commonly used methods: noninvasive positive pressure mask ventilation (NIPPMV), high-flow nasal cannula (HFNС), noninvasive positive pressure helmet ventilation (NIPPHV). OBJECTIVE: Comparison of the effectiveness of respiratory support methods depending on their effect on gas exchange in patients with mild to moderate respiratory failure in the early period after cardiac surgery. MATERIALS AND METHODS: The study included 42 cardiac surgery patients with 200 < P/F < 300 who were divided into 3 groups depending on the methods of respiratory support used (NIPPMV, HFNС, NIPPHV). The main point of the study is to assess the dynamics of the gas exchange indicators before, during and after their use. RESULTS: All three methods of NIVL contribute to a statistically significant improvement in gas exchange during NIVL, which persisted after the end of therapy (SpO2, PaO2, P/F, Qsp/Qt). In the group with the use of NIPPMV and HFNС an increase in the oxyhemoglobin fraction. In the course of this study, no data were revealed on changes in PaCO2. The largest increase in SpO2 was revealed in groups using a mask and helmet, but at the end of the NIVL session there were no statistically significant differences between the groups. A decrease in the proportion of patients with P/F < 300 after a single session in the NIPPMV group by 2 times, in the HFNC group — by 1.6 times, in the NIPPHV group — by 3.5 times. CONCLUSIONS: Conducting noninvasive respiratory support significantly improves the indicators of oxygenating lung function in the early postoperative period in cardiac surgery patients. NIPPHV and NIPPMV are more effective compared to HFNC. When using a helmet, a higher level of support is required.